Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 4
1982 6
1983 2
1984 2
1985 3
1986 4
1987 5
1988 3
1989 8
1990 7
1991 8
1992 4
1993 7
1994 3
1995 3
1996 5
1997 3
1998 9
1999 7
2000 20
2001 16
2002 14
2003 13
2004 8
2005 18
2006 13
2007 7
2008 8
2009 14
2010 13
2011 10
2012 9
2013 17
2014 20
2015 6
2016 8
2017 8
2018 12
2019 11
2020 6
2021 3
2022 10
2023 5
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
X-Linked Lymphoproliferative Disease.
Meyer L, Hines M, Zhang K, Nichols KE. Meyer L, et al. 2004 Feb 27 [updated 2024 May 16]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2004 Feb 27 [updated 2024 May 16]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301580 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: X-linked lymphoproliferative disease (XLP) in general is characterized by an inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosi …
CLINICAL CHARACTERISTICS: X-linked lymphoproliferative disease (XLP) in general is characterized by an in …
X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
Panchal N, Booth C, Cannons JL, Schwartzberg PL. Panchal N, et al. Front Immunol. 2018 Apr 4;9:666. doi: 10.3389/fimmu.2018.00666. eCollection 2018. Front Immunol. 2018. PMID: 29670631 Free PMC article. Review.
X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein-Barr virus (EBV). ...Molecular cloning of the causative gene, SH2D1A, has provided …
X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoprolifera …
X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.
Bassiri H, Janice Yeo WC, Rothman J, Koretzky GA, Nichols KE. Bassiri H, et al. Immunol Res. 2008;42(1-3):145-59. doi: 10.1007/s12026-008-8048-7. Immunol Res. 2008. PMID: 18815745 Review.
A major focus of our research is to understand the molecular and cellular basis of X-linked lymphoproliferative disease (XLP), a rare and often fatal immunodeficiency caused by mutations in the SH2D1A gene, which encodes the adaptor molecule SAP …
A major focus of our research is to understand the molecular and cellular basis of X-linked lymphoproliferative dise …
X-linked lymphoproliferative syndrome.
Sullivan JL, Woda BA. Sullivan JL, et al. Immunodefic Rev. 1989;1(4):325-47. Immunodefic Rev. 1989. PMID: 2561059 Review.
The X-linked lymphoproliferative (XLP) syndrome is characterized by a selective immunodeficiency to Epstein-Barr virus (EBV) manifested by severe or fatal infectious mononucleosis and acquired immunodeficiency. ...These probes make detection of carrier females and p …
The X-linked lymphoproliferative (XLP) syndrome is characterized by a selective immunodeficiency to Epstein-Barr virus (EBV) m …
X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C, Latour S. Aguilar C, et al. J Clin Immunol. 2015 May;35(4):331-8. doi: 10.1007/s10875-015-0141-9. Epub 2015 Mar 4. J Clin Immunol. 2015. PMID: 25737324 Review.
X-linked inhibitor of apoptosis (XIAP) deficiency (also known as X-linked lymphoproliferative syndrome type 2, XLP-2) is a rare primary immunodeficiency. Since the disease was first described in 2006, more than 70 patients suffering from XIAP-deficiency have been re …
X-linked inhibitor of apoptosis (XIAP) deficiency (also known as X-linked lymphoproliferative syndrome type 2, XLP-2) is a rar …
X-linked lymphoproliferative disease: a progressive immunodeficiency.
Morra M, Howie D, Grande MS, Sayos J, Wang N, Wu C, Engel P, Terhorst C. Morra M, et al. Annu Rev Immunol. 2001;19:657-82. doi: 10.1146/annurev.immunol.19.1.657. Annu Rev Immunol. 2001. PMID: 11244050 Review.
Our understanding of the X-linked lymphoproliferative syndrome (XLP) has advanced significantly in the last two years. The gene that is altered in the condition (SAP/SH2D1A) has been cloned and its protein crystal structure solved. ...Further analyses of the SAP/SH2 …
Our understanding of the X-linked lymphoproliferative syndrome (XLP) has advanced significantly in the last two years. The gen …
X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
Veillette A, Pérez-Quintero LA, Latour S. Veillette A, et al. Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):614-22. doi: 10.1097/ACI.0000000000000008. Curr Opin Allergy Clin Immunol. 2013. PMID: 24113228 Review.
PURPOSE OF REVIEW: X-linked lymphoproliferative (XLP) syndromes and related autosomal disorders are severe primary immune deficiencies triggered by infection with Epstein-Barr virus (EBV), the causative agent of infectious mononucleosis. ...RECENT FINDINGS: M …
PURPOSE OF REVIEW: X-linked lymphoproliferative (XLP) syndromes and related autosomal disorders are severe primary immu …
X-linked lymphoproliferative disease: genetic lesions and clinical consequences.
MacGinnitie AJ, Geha R. MacGinnitie AJ, et al. Curr Allergy Asthma Rep. 2002 Sep;2(5):361-7. doi: 10.1007/s11882-002-0068-0. Curr Allergy Asthma Rep. 2002. PMID: 12165201 Review.
X-linked lymphoproliferative disorder (XLP) was first described almost 30 years ago; remarkably, the three major manifestations of XLP, fulminant infectious mononucleosis (FIM), lymphoma, and dysgammaglobulinemia, are all described in the report of the initia …
X-linked lymphoproliferative disorder (XLP) was first described almost 30 years ago; remarkably, the three major manifestation …
Fatal unexpected death due to X-linked lymphoproliferative disease.
Mu J, Xue D, Li M, Wang T, Ma Q, Dong H. Mu J, et al. Leg Med (Tokyo). 2021 Sep;52:101900. doi: 10.1016/j.legalmed.2021.101900. Epub 2021 May 1. Leg Med (Tokyo). 2021. PMID: 34023582
X-linked lymphoproliferative disease (XLP) is a rare immunodeficiency disease characterized by severe immune disorder and extreme vulnerability to Epstein-Barr virus (EBV) infections. ...The cause of death of the boy was ascribed to XLP. …
X-linked lymphoproliferative disease (XLP) is a rare immunodeficiency disease characterized by severe imm …
336 results